566 related articles for article (PubMed ID: 12833016)
1. Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis.
Tosti A; Piraccini BM; Pazzaglia M; Vincenzi C
J Am Acad Dermatol; 2003 Jul; 49(1):96-8. PubMed ID: 12833016
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double-blind placebo-controlled trial.
Tosti A; Iorizzo M; Botta GL; Milani M
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1243-7. PubMed ID: 17062039
[TBL] [Abstract][Full Text] [Related]
3. Combined oral pulse and topical corticosteroid therapy for severe alopecia areata in children: a long-term follow-up study.
Lalosevic J; Gajic-Veljic M; Bonaci-Nikolic B; Nikolic M
Dermatol Ther; 2015; 28(5):309-17. PubMed ID: 26179196
[TBL] [Abstract][Full Text] [Related]
4. The use of 0.25% zinc pyrithione spray does not enhance the efficacy of clobetasol propionate 0.05% foam in the treatment of psoriasis.
Housman TS; Keil KA; Mellen BG; McCarty MA; Fleischer AB; Feldman SR
J Am Acad Dermatol; 2003 Jul; 49(1):79-82. PubMed ID: 12833013
[TBL] [Abstract][Full Text] [Related]
5. Five-year experience in the treatment of alopecia areata with DPC.
El-Zawahry BM; Bassiouny DA; Khella A; Zaki NS
J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):264-9. PubMed ID: 19744175
[TBL] [Abstract][Full Text] [Related]
6. Clobetasol propionate, 0.05%, vs hydrocortisone, 1%, for alopecia areata in children: a randomized clinical trial.
Lenane P; Macarthur C; Parkin PC; Krafchik B; DeGroot J; Khambalia A; Pope E
JAMA Dermatol; 2014 Jan; 150(1):47-50. PubMed ID: 24226568
[TBL] [Abstract][Full Text] [Related]
7. Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata.
Olsen EA; Carson SC; Turney EA
Arch Dermatol; 1992 Nov; 128(11):1467-73. PubMed ID: 1444500
[TBL] [Abstract][Full Text] [Related]
8. Alopecia areata treated with topical minoxidil.
Weiss VC; West DP; Fu TS; Robinson LA; Cook B; Cohen RL; Chambers DA
Arch Dermatol; 1984 Apr; 120(4):457-63. PubMed ID: 6703751
[TBL] [Abstract][Full Text] [Related]
9. [Intravenous pulse methylprednisolone therapy for severe alopecia areata: an open study of 66 patients].
Assouly P; Reygagne P; Jouanique C; Matard B; Marechal E; Reynert P; Bachelez H; Dubertret L
Ann Dermatol Venereol; 2003 Mar; 130(3):326-30. PubMed ID: 12746668
[TBL] [Abstract][Full Text] [Related]
10. The use of topical diphenylcyclopropenone for the treatment of extensive alopecia areata.
Cotellessa C; Peris K; Caracciolo E; Mordenti C; Chimenti S
J Am Acad Dermatol; 2001 Jan; 44(1):73-6. PubMed ID: 11148480
[TBL] [Abstract][Full Text] [Related]
11. Clobetasol propionate shampoo 0.05%: a new option to treat patients with moderate to severe scalp psoriasis.
Jarratt M; Breneman D; Gottlieb AB; Poulin Y; Liu Y; Foley V
J Drugs Dermatol; 2004; 3(4):367-73. PubMed ID: 15303780
[TBL] [Abstract][Full Text] [Related]
12. PUVA treatment of alopecia areata.
Claudy AL; Gagnaire D
Arch Dermatol; 1983 Dec; 119(12):975-8. PubMed ID: 6651314
[TBL] [Abstract][Full Text] [Related]
13. Congenital alopecia areata.
Lenane P; Pope E; Krafchik B
J Am Acad Dermatol; 2005 Feb; 52(2 Suppl 1):8-11. PubMed ID: 15692503
[TBL] [Abstract][Full Text] [Related]
14. Pulse corticosteroid therapy for alopecia areata: study of 139 patients.
Nakajima T; Inui S; Itami S
Dermatology; 2007; 215(4):320-4. PubMed ID: 17911990
[TBL] [Abstract][Full Text] [Related]
15. Nail psoriasis: a combined treatment with 8% clobetasol nail lacquer and tacalcitol ointment.
Sánchez Regaña M; Márquez Balbás G; Umbert Millet P
J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):963-9. PubMed ID: 18410337
[TBL] [Abstract][Full Text] [Related]
16. Topical 0.05% clobetasol propionate versus 1% pimecrolimus ointment in vitiligo.
Coskun B; Saral Y; Turgut D
Eur J Dermatol; 2005; 15(2):88-91. PubMed ID: 15757818
[TBL] [Abstract][Full Text] [Related]
17. The PUVA-turban as a new option of applying a dilute psoralen solution selectively to the scalp of patients with alopecia areata.
Behrens-Williams SC; Leiter U; Schiener R; Weidmann M; Peter RU; Kerscher M
J Am Acad Dermatol; 2001 Feb; 44(2):248-52. PubMed ID: 11174382
[TBL] [Abstract][Full Text] [Related]
18. Clobetasol propionate 0.05% spray for the management of moderate-to-severe plaque psoriasis of the scalp: results from a randomized controlled trial.
Sofen H; Hudson CP; Cook-Bolden FE; Preston N; Colón LE; Colón LE; Caveney SW; Gottschalk RW
J Drugs Dermatol; 2011 Aug; 10(8):885-92. PubMed ID: 21818510
[TBL] [Abstract][Full Text] [Related]
19. Treatment of alopecia universalis with topical Janus kinase inhibitors - a double blind, placebo, and active controlled pilot study.
Bokhari L; Sinclair R
Int J Dermatol; 2018 Dec; 57(12):1464-1470. PubMed ID: 30160787
[TBL] [Abstract][Full Text] [Related]
20. A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo.
Lepe V; Moncada B; Castanedo-Cazares JP; Torres-Alvarez MB; Ortiz CA; Torres-Rubalcava AB
Arch Dermatol; 2003 May; 139(5):581-5. PubMed ID: 12756094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
